| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |